Isradipine therapy in hypertensive pediatric patients

Annals of Pharmacotherapy

Volumn 31, Issue 6, 1997, Pages 704-707

  Johnson, Cary E ^a,b   Jacobson, Pamala A ^a,b   Song, Min H ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

Hypertension; Isradipine; Pediatrics

Indexed keywords

ANTIHYPERTENSIVE AGENT; ISRADIPINE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FEMALE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 0030969452     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100606     Document Type: Article

References (14)

1. Sinaiko AR. Pharmacologic management of childhood hypertension. Ped Clin North Am 1993;40:195-212.
2. McEnery PT, Stablein DM, Arbus G, Tejani A. Renal transplantation in children: a report of the North American pediatric renal transplant cooperative study. N Engl J Med 1992;326:1727-32.
3. Weir MR. Calcium channel blockers in organ transplantation: important new therapeutic modalities. J Am Soc Nephrol 1990;1(suppl):S28-38.
4. First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994;4(suppl):S30-6.
5. Gruskin AB, Shermine D, Fleischmann LE, Atiyeh BA. Application since 1980 of antihypertensive agents to treat pediatric disease. J Hum Hypertens 1994;8:381-8.
6. Shahar E, Sagy M, Koren G, Barzilay Z. Calcium blocking agents in pediatric emergency care. Ped Emerg Care 1990;6:52-7.
7. Rosen WJ, Johnson CE. Evaluation of five procedures for measuring nonstandard doses of nifedipine liquid. Am J Hosp Pharm 1989;46: 2313-7.
8. Rocha-Goncalves F, Moura B, Pereira-Miguel JM, Mariano-Pego G. Isradipine in the treatment of mild-to-moderate hypertension in geriatric patients. Am J Hypertens 1994;7(suppl):S64-6.
9. Isradipine. In: McEvoy GK, ed. AHFS drug information 1996. Bethesda, MD: American Society of Health-System Pharmacists, 1996:1295-7.
10. Walton T, Symes LR. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension. Clin Pharm 1993;12: 261-75.
11. Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Ther Drug Monit 1991;13:490-5.
12. Fitton A, Benfield P. Isradipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1990;40:31-74.
13. Sinaiko AR. Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics. J Hum Hypertens 1994;8:389-94.
14. MacDonald JL, Johnson CE, Jacobson PA. Stability of isradipine in an extemporaneously compounded oral liquid. Am J Hosp Pharm 1994;51: 2409-11.